Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making
The controversy surrounding the use of hydroxychloroquine (HCQ), an antimalarial drug, for COVID-19 has raised numerous ethical and policy problems. Since the suggestion that HCQ has potential for COVID-19, there have been varying responses from clinicians and healthcare institutions, ranging from a...
Authors: | ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2020
|
In: |
Journal of medical ethics
Year: 2020, Volume: 46, Issue: 9, Pages: 574-578 |
Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
LEADER | 00000caa a22000002 4500 | ||
---|---|---|---|
001 | 1816163201 | ||
003 | DE-627 | ||
005 | 20230428063539.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220908s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/medethics-2020-106306 |2 doi | |
035 | |a (DE-627)1816163201 | ||
035 | |a (DE-599)KXP1816163201 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 1 |2 ssgn | ||
100 | 1 | |a Aquino, S. J. |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The controversy surrounding the use of hydroxychloroquine (HCQ), an antimalarial drug, for COVID-19 has raised numerous ethical and policy problems. Since the suggestion that HCQ has potential for COVID-19, there have been varying responses from clinicians and healthcare institutions, ranging from adoption of protocols using HCQ for routine care to the conduct of randomised controlled trials to an effective system-wide prohibition on its use for COVID-19. In this article, we argue that the concept of ‘disease public profile’ has become a prominent, if not the sole, determinant in decision-making across various healthcare responses to the pandemic. In the case of COVID-19, the disease’s public profile is based on clinical and non-clinical factors that include contagiousness, clinical presentation and media coverage. In particular, we briefly examine the dangers of a heightened public profile in magnifying the inequality of diseases and undermining three key ethical concepts, namely (1) evidence-based practice, (2) sustainable allocation and (3) meaningful consent. | ||
601 | |a COVID-19 | ||
700 | 1 | |a Cabrera, Nicolo |e VerfasserIn |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d London : BMJ Publ., 1975 |g 46(2020), 9, Seite 574-578 |h Online-Ressource |w (DE-627)323607802 |w (DE-600)2026397-1 |w (DE-576)260773972 |x 1473-4257 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2020 |g number:9 |g pages:574-578 |
856 | |u https://europepmc.org/articles/pmc7371492?pdf=render |x unpaywall |z Vermutlich kostenfreier Zugang |h repository [oa repository (via OAI-PMH doi match)] | ||
856 | 4 | 0 | |u https://doi.org/10.1136/medethics-2020-106306 |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u http://jme.bmj.com/content/46/9/574.abstract |x Verlag |z kostenfrei |3 Volltext |
935 | |a mteo | ||
951 | |a AR | ||
ELC | |a 1 | ||
ITA | |a 1 |t 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 4185617151 | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 1816163201 | ||
LOK | |0 005 20220908053753 | ||
LOK | |0 008 220908||||||||||||||||ger||||||| | ||
LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-03#36F11987C32CA18331F7301FC5769FC59012A1C4 | ||
LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-Tue135 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 935 |a ixzs |a ixrk |a zota | ||
OAS | |a 1 | ||
ORI | |a SA-MARC-ixtheoa001.raw |